D-1438-2019 Class III Terminated

Recalled by Amneal Pharmaceuticals, Inc. — Brookhaven, NY

FDA drug recall D-1438-2019 was initiated by Amneal Pharmaceuticals, Inc. on Sep 25, 2017 and is designated Class III. Reason for recall: Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets. The recall status is terminated (terminated Aug 8, 2019). Affected quantity: 19104 units.

Recall details

Product Type
Drugs
Report Date
Jul 10, 2019
Initiation Date
Sep 25, 2017
Termination Date
Aug 8, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19104 units

Product description

Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01

Reason for recall

Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

Distribution pattern

Nationwide within the United States

Code information

Lot #: HL05715, HL05815, Exp. 11/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1438-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1438-2019. Report a data issue: hello@regdatalab.com.